Dupilumab Achieves Early Disease Control in Bullous Pemphigoid: A Case Series with TARC-based Biomarker Evaluation

Dupilumab Achieves Early Disease Control in Bullous Pemphigoid: A Case Series with TARC-based Biomarker Evaluation

Saved in:

Bibliographic Details
Main Authors:	Saori Takamura, Tomoo Fukuda
Format:	Article
Language:	English
Published:	Medical Journals Sweden 2025-07-01
Series:	Acta Dermato-Venereologica
Subjects:	bullous pemphigoid dupilumab biologic therapy IL-4 IL-13 disease activity biomarkers
Online Access:	https://medicaljournalssweden.se/actadv/article/view/43999
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and safety of dupilumab in patients with moderate-to-severe bullous pemphigoid: a systematic review and meta-analysis
by: Júlia Opolski Nunes da Silva, et al.
Published: (2025-08-01)

Concomitant use of dupilumab with glucocorticoid in bullous pemphigoid reduces disease severity: A preliminary study
by: Lingyu Hu, et al.
Published: (2023-07-01)

Time to Disease Control with Dupilumab for Bullous Pemphigoid: A Systematic Review and Meta-analysis
by: Laurence Mainville, et al.
Published: (2025-05-01)

Bullous pemphigoid and its association with neurological diseases
by: Charl P. Smit, et al.
Published: (2024-02-01)

Dupilumab as a novel steroid-sparing treatment for pemphigoid gestationis: A new case report and review of literature
by: Celine H. Phong, MD, et al.
Published: (2025-06-01)

Aberrant glycosylation patterns as potential biomarkers for diagnosis and disease progression in bullous pemphigoid
by: Haijun Miao, et al.
Published: (2025-05-01)

Pathogenesis, diagnosis and treatment of immune checkpoint inhibitor related bullous pemphigoid
by: Yi SUN, et al.
Published: (2025-04-01)

Real‐life retrospective multicentre study to describe the use of dupilumab in paediatric patients with atopic dermatitis in Spain: Patient profile, effectiveness and safety
by: Eulalia Baselga Torres, et al.
Published: (2025-06-01)

Research progress on the association of bullous pemphigoid with type 2 diabetes mellitus
by: ZHANG Ruohan, et al.
Published: (2025-03-01)

Correction: Evaluation of a novel chemiluminescent immunoassay for autoantibody detection in pemphigus and bullous pemphigoid
by: Na Zhang, et al.
Published: (2025-07-01)

Home‐based collaborative management of bullous pemphigoid with delayed seropositive conversion of anti‐BP180‐NC16a antibody
by: Hiromitsu Yamashita, et al.
Published: (2025-07-01)

Bullous pemphigoid of Lever against the background of combined somatic pathology
by: E. N. Efanova, et al.
Published: (2021-06-01)

Coexistence of bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata: a case report of multifactorial autoimmunity in a surgical context
by: Shanlin Li, et al.
Published: (2025-08-01)

Pemphigoid diseases as immune-related adverse effect following immune checkpoint inhibitors: A clinical case series of a diverse spectrum
by: Nika Kotnik, MD, et al.
Published: (2025-07-01)

Incidence of upper respiratory tract infections with biological therapies in moderate to severe atopic dermatitis: a systematic review and meta-analysis
by: Rose Alraddadi, et al.
Published: (2025-04-01)

Serum levels of interleukin-17, -18, -22, and -25 in patients with bullous pemphigoid before and after treatment
by: Xinyi Hong, et al.
Published: (2025-07-01)

Pathogenetic role of IL-4 and IL-13 in atopic dermatitis: The inhibitory pathways
by: D. Sh. Macharadze
Published: (2025-03-01)

Dupilumab for Chronic Rhinosinusitis with Primary Nasal Polyps: a Case Report and Literature Review
by: Deng M, et al.
Published: (2025-04-01)

Demographic characteristics and disease severity associated with IgA/IgG deposition patterns in autoimmune bullous diseases: a cohort study based on a registry database
by: Jishu Li, et al.
Published: (2025-05-01)

The relevance of HLA class II histocompatibility gens in predicting the risk of developing several bullous dermatoses
by: Marianna Drozhdina, et al.
Published: (2025-03-01)

Emergence of bullous pemphigoid under treatment of mycosis fungoides with mogamulizumab
by: Lukas D. Uleer, et al.
Published: (2025-06-01)

Pharmacogenetic biomarkers associated with risk of developing severe drug eruptions and clinical implementation of HLA genetic testing
by: Taisei Mushiroda
Published: (2025-07-01)

Dupilumab as Immunomodulatory Rescue for Severe Recalcitrant Pemphigus Vulgaris: A Case Report and Literature Review
by: Boonpethkaew S, et al.
Published: (2025-07-01)

Achievement of Control of Severe Bronchial Asthma When Using Dupilumab
by: O. V. Kazmerchuk, et al.
Published: (2024-11-01)

Emerging Therapies in the Treatment of Prurigo Nodularis: Biological Therapy and Systematic Review of Literature
by: Gaetano Licata, et al.
Published: (2025-05-01)

Difficulties in the differential diagnosis of granulomatosis with polyangiitis and scarring pemphigoid
by: N. A. Magdeeva, et al.
Published: (2020-10-01)

Successful Treatment of Pediatric Atopic Prurigo Nodularis with Dupilumab
by: Zhang Y, et al.
Published: (2025-06-01)

Delayed perforation after cold snare polypectomy for small colonic polyps in a patient receiving oral corticosteroids
by: Hirotoshi Iwano, et al.
Published: (2023-04-01)

The role of epithelial alarmins and Th2 cytokines in the inflammatory response in allergic rhinitis
by: V. V. Makarevich, et al.
Published: (2024-11-01)

Bullous Eruption with Cholestasis in Pregnancy
by: Sara Al Janahi, et al.
Published: (2025-06-01)

IL-4 and IL-13 in Cardiovascular Disease: From Immune Modulation to Therapeutic Possibilities &ndash; A Narrative Review
by: Kılıç AT, et al.
Published: (2025-08-01)

VARIANTS OF С-572G OF IL6 AND С-1112T OF IL13 GENES POLYMORPHISMS AND FEATURES OF THE CLINICAL COURSE OF DIFFUSE TOXIC GOITER
by: N. E. Peikrishvili, et al.
Published: (2017-06-01)

Comparative short-term efficacy of Janus kinase 1 inhibitors and anti-interleukin-13 antibodies in atopic dermatitis: a retrospective cohort analysis based on real-world data
by: Emi Sato, et al.
Published: (2025-08-01)

Dupilumab for Chronic Obstructive Pulmonary Disease: A Systematic Review
by: Julia Young, et al.
Published: (2025-02-01)

Blistering Diseases in a Tertiary Care Hospital: A 10-year Audit
by: Niraj Parajuli, et al.
Published: (2020-10-01)

Blistering Diseases in a Tertiary Care Hospital: A 10-year Audit
by: Niraj Parajuli, et al.
Published: (2020-10-01)

Localization of Lesions in Autoimmune Blistering Diseases Is Independent of Site-Specific Target Antigen Expression
by: Tina Rastegar Lari, et al.
Published: (2025-01-01)

High Prevalence of Lash Collarettes in Patients with Atopic Dermatitis Treated with Dupilumab
by: Ilaria Trave, et al.
Published: (2025-08-01)

Dupilumab for management of capecitabine-induced hand-foot syndrome
by: Ian Nykaza, BS, et al.
Published: (2025-09-01)

Pemphigoid gestationis associated with gestational trophoblastic neoplasia: A case report
by: Jasmine H. Wong, et al.
Published: (2025-06-01)